rs771877780

Variant names:

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS2_Supporting

The NM_004006.3(DMD):c.7555G>A(p.Asp2519Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000058 in 1,207,821 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 23)

Exomes 𝑓: 0.0000046 ( 0 hom. 3 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:3B:1

Conservation

PhyloP100: 6.67

Publications

1 publications found

Variant links:

Genes affected

DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

DMD Gene-Disease associations (from GenCC):

Becker muscular dystrophy
Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
dilated cardiomyopathy 3B
Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
Duchenne and Becker muscular dystrophy
Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
Duchenne muscular dystrophy
Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
progressive muscular dystrophy
Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
familial isolated dilated cardiomyopathy
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
non-syndromic X-linked intellectual disability
Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

DMD links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.27373123).

BS2

High AC in GnomAdExome4 at 5 XL,AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DMD	NM_004006.3 link	c.7555G>A	p.Asp2519Asn	missense_variant	Exon 52 of 79	ENST00000357033.9	NP_003997.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DMD	ENST00000357033.9 link	c.7555G>A	p.Asp2519Asn	missense_variant	Exon 52 of 79	1	NM_004006.3	ENSP00000354923.3

Frequencies

GnomAD3 genomes

AF:

0.0000179

AC:

AN:

111885

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.000559

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000272

AC:

AN:

183507

AF XY:

0.0000442

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.000361

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.00000456

AC:

AN:

1095936

Hom.:

Cov.:

AF XY:

0.00000830

AC XY:

AN XY:

361320

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

26363

American (AMR)

AF:

0.00

AC:

AN:

35202

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

19369

East Asian (EAS)

AF:

0.000166

AC:

AN:

30187

South Asian (SAS)

AF:

0.00

AC:

AN:

54100

European-Finnish (FIN)

AF:

0.00

AC:

AN:

40526

Middle Eastern (MID)

AF:

0.00

AC:

AN:

4128

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

840043

Other (OTH)

AF:

0.00

AC:

AN:

46018

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.450

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000179

AC:

AN:

111885

Hom.:

Cov.:

AF XY:

0.0000587

AC XY:

AN XY:

34065

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

30722

American (AMR)

AF:

0.00

AC:

AN:

10551

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

2653

East Asian (EAS)

AF:

0.000559

AC:

AN:

3575

South Asian (SAS)

AF:

0.00

AC:

AN:

2675

European-Finnish (FIN)

AF:

0.00

AC:

AN:

6065

Middle Eastern (MID)

AF:

0.00

AC:

AN:

237

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

53215

Other (OTH)

AF:

0.00

AC:

AN:

1509

Age Distribution

Genome Hom

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00

Hom.:

Bravo

AF:

0.0000151

ExAC

AF:

0.0000494

AC:

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:3Uncertain:3Benign:1

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not provided

Pathogenic:2Uncertain:1

May 04, 2015

GeneDx

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The D2519N missense variant has been reported previously as de novo in a male with elevated CK level, calf hypertrophy, and a clinical diagnosis of Duchenne muscular dystrophy (Wang et al., 2014). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D2519N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. Therefore, D2519N is interpreted as a pathogenic variant. -

Jun 01, 2017

CeGaT Center for Human Genetics Tuebingen

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

May 04, 2022

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The DMD c.7555G>A; p.Asp2519Asn variant (rs771877780) is reported in the literature as occurring de novo in a male diagnosed with muscular dystrophy and in a female with an increased CK undergoing carrier screening (Han 2020, Wang 2014). This variant is reported in the ClinVar database with conflicting classifications (Variation ID: 427170). This variant is found in the East Asian population with an allele frequency of 0.04% (6/14,879 alleles, including 4 hemizygotes) in the Genome Aggregation Database. The aspartic acid at codon 2519 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.254). Although the number of hemizygotes in the Genome Aggregation Database indicates this variant may be a rare benign variant, due to conflicting information, the clinical significance of the p.Asp2519Asn variant is uncertain at this time. References: Han S et al. Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing. Biomed Res Int. 2020 Sep 27;2020:8396429. PMID: 33029525. Wang Y et al. Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy. Mol Genet Genomics. 2014 Oct;289(5):1013-21. PMID: 24770780. -

Duchenne muscular dystrophy

Pathogenic:1Benign:1

Aug 16, 2020

Department of Obstetrics, Zhejiang Provincial People's Hospital, Zhejiang Provincial People's Hospital

Significance:Likely pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The D2519N missense variant was not observed in 1000 Genome database, ESP 6500 and genomAD. It was a presumed de novo variant in a female with elevated CK and harboring non-DMD family history. This substitution occurs at a position that is conserved across species (SIFT and PolyPhen predicted it deleterious and probably damaging). Therefore, D2519N is interpreted as a likely pathogenic variant. -

Mar 17, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not specified

Uncertain:1

Oct 19, 2023

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Variant summary: DMD c.7555G>A (p.Asp2519Asn) results in a conservative amino acid change located in the central rod domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.9e-05 in 205897 control chromosomes, predominantly at a frequency of 0.0004 within the East Asian subpopulation in the gnomAD database, including 4 hemizygotes. The available data on variant occurrences in the general population suggest the variant could be a benign polymorphism found predominantly in individuals of East Asian ancestry, but are ultimately insufficient to allow any conclusion about variant significance. c.7555G>A has been reported in the literature as de novo in a male child affected with Duchenne Muscular Dystrophy (DMD) (Wang_2013) as well as in a female carrier with slightly elevated creatine kinase levels but no family history of DMD (Han_2020). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33029525, 24770780). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 with conflicting assessments. Three submitters classified the variant as pathogenic/likely pathogenic, two classified it as uncertain significance, and one submitter classified it as benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Cardiovascular phenotype

Uncertain:1

Jun 25, 2022

Ambry Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The p.D2519N variant (also known as c.7555G>A), located in coding exon 52 of the DMD gene, results from a G to A substitution at nucleotide position 7555. The aspartic acid at codon 2519 is replaced by asparagine, an amino acid with highly similar properties. This variant was described as de novo in one male reported to have symptoms of Duchenne muscular dystrophy (DMD), although clinical details were limited (Wang Y et al. Mol Genet Genomics, 2014 Oct;289:1013-21). This variant was also detected in a female with elevated creatine kinase (CK) levels who had no skeletal muscular or cardiac findings, and known family history of DMD (Han S et al. Biomed Res Int, 2020 Sep;2020:8396429). Based on data from gnomAD, the A allele has an overall frequency of 0.0029%( 6/205497) total alleles studied, with 4 hemizygotes observed. The highest observed frequency was 0.0403% (6/14879) of East Asian alleles. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.15

BayesDel_addAF

Benign

-0.38

BayesDel_noAF

Benign

-0.47

CADD

Uncertain

(source)

DANN

Pathogenic

1.0

DEOGEN2

Benign

0.33

.;T;T;.;.;T;.;.;T

FATHMM_MKL

Uncertain

0.95

LIST_S2

Pathogenic

0.98

D;.;.;.;D;.;D;D;.

M_CAP

Uncertain

0.16

MetaRNN

Benign

0.27

T;T;T;T;T;T;T;T;T

MetaSVM

Benign

-0.35

PhyloP100

6.7

PrimateAI

Uncertain

0.58

PROVEAN

Uncertain

-3.0

D;D;D;D;.;D;.;D;D

REVEL

Benign

0.25

Sift

Uncertain

0.0020

D;D;D;D;.;D;.;D;D

Sift4G

Uncertain

0.0050

D;D;D;D;D;D;D;D;D

Polyphen

1.0, 1.0, 0.99

.;D;D;D;.;D;.;.;D

Vest4

0.57, 0.52, 0.52, 0.69, 0.61, 0.53, 0.80, 0.42

MutPred

0.46

.;.;.;.;.;.;.;Loss of ubiquitination at K2514 (P = 0.0705);.;

MVP

0.71

MPC

0.070

ClinPred

0.69

GERP RS

5.2

gMVP

0.52

Mutation Taster

=78/22

disease causing (ClinVar)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over